Freenome
@freenome
Freenome is a high-growth biotech company developing next-generation blood tests to detect cancer in its earliest, most treatable stages.
ID: 3295317478
https://freenome.com 23-05-2015 14:02:08
311 Tweet
3,3K Followers
293 Following
We look back today on Elise Reuter's MedTech Dive Q&A with our CEO, Mike Nolan. In the article, he states, "For [Freenome], the competition is cancer. We're really driven to beat cancer. That's the motivation." How's that for a mission? medtechdive.com/news/mike-nola…
Thank you to MedTech Dive for featuring the initiation of our PROACT LUNG Clinical Study. Through PROACT LUNG, we aim to validate the clinical efficacy of our blood test for the early detection of lung cancer. More below: medtechdive.com/news/freenome-… #CancerResearch #ClinicalTrials
The American Lung Association highlights that only 4.5% of high-risk individuals nationally are screened for #LungCancer. This data demonstrates the need for widespread, effective screening. Our focus is on bridging these screening gaps through innovative, non-invasive testing methods.
From American Cancer Society: colorectal cancer is the 3rd most commonly diagnosed cancer for both men and women, estimating >150K CRC cases in the US in 2024. We are building blood tests designed to screen for CRC, aiming to help patients detect CRC earlier in its more treatable stages.